Estrogen-induced tumorigenesis in the pituitary gland of TGF-β(+/-) knockout mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1407, Issue 1, 1998, Pages 79-83

  Shida, Naoki ^a   Ikeda, Hidetoshi ^a   Yoshimoto, Takashi ^a   Oshima, Masanobu ^b   Taketo, Makoto M ^c   Miyoshi, Ichiro ^d  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C57BL 6J mouse; Estrogen; Knockout mouse; Pituitary adenoma; Transforming growth factor ; Transforming growth factor receptor type II

Indexed keywords

ESTRADIOL; ESTROGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARCINOGENESIS; CONTROLLED STUDY; HISTOLOGY; HYPOPHYSIS TUMOR; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031709503     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(98)00024-6     Document Type: Article

References (19)

1. Gorski J., Wendell D., Gregg D., Chun T.Y. Estrogens and the genetic control of tumor growth. Prog. Clin. Biol. Res. 396:1997;233-243.
2. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushanaky K., Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27-deficient mice. Cell. 85:1996;733-744.
3. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.C., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27. Cell. 85:1996;721-732.
4. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., Nakayama K. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
5. Jacks T., Frazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effect of an Rb mutation in the mouse. Nature. 359:1992;295-300.
6. Ikeda H., Yoshimoto T., Shida N. Molecular analysis of p21 and p27 genes in human pituitary adenomas. Br. J. Cancer. 76:1997;1119-1123.
7. H. Ikeda, Molecular analysis of pituitary adenoma, Brain Pathol. 7 (1997) 1165 (abstr).
8. Fujiwara K., Ikeda H., Yoshimoto T. Abnormalities in the expression of genes, mRNA, and proteins of transforming growth factor-β receptor type I and type II in human pituitary adenomas. Clin. Neuropathol. 17:1998;19-26.
9. Pastorcic M., De A., Boyadjieva N., Vale W., Sarkar D.K. Reduction in the expression and action of transforming growth factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res. 55:1995;4892-4898.
10. Ravitz M.J., Yan S., Herr K.D., Wenner C.E. Transforming growth factor β-induced activation of cyclin E-cdk2 kinase and down-regulation of p27 in C3H 10T1/2 mouse fibroblast. Cancer Res. 55:1995;1413-1416.
11. Laiho M., DeCaprio J.A., Ludlow J.W., Livingston D.M., Masague J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell. 62:1990;175-185.
12. Serra R., Moses H. Tumor suppressor genes in the TGF-β signaling pathway. Nature Med. 2:1996;390-391.
13. Ohshima M., Ohshima H., Taketo M. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:1996;297-302.
14. Clayton C., Schechter J., Finch C. The development of mammotroph adenomas in pituitaries of aging female C57BL/6J mice. Exp. Gerontol. 19:1984;313-320.
15. Felicio L., Nelson J.F., Finch C.E. Spontaneous pituitary tumorigenesis and plasma oestradiol in aging female C57/6J mice. Exp. Gerontol. 15:1980;139-143.
16. Schechter J.E., Felicio L.S., Nelson J.F., Finch C. Pituitary tumorigenesis in aging female C57BL/6J mice: a light and electron microscopic study. Anat. Rec. 199:1981;423-432.
17. Scully K.M., Gleiberman A.S., Lindzey J., Lubahn D.B., Korach K.S., Rosenfeld M.G. Role of estrogen receptor-α in the anterior pituitary gland. Mol. Endocrinol. 11:1997;674-681.
18. De A., Morgan T.E., Speth R.C., Boyadjieva N., Sarkar D.K. Pituitary lactotrophes express transforming growth factor β (TGF-β) type II receptor mRNA and protein and contains 125I-TGF 1 binding sites. J. Endocrinol. 149:1996;19-27.
19. Brattain M.G., Markowitz S.D., Willson J.K.V. The type II transforming growth factor-β receptor as a tumor-suppressor gene. Curr. Opin. Oncol. 8:1996;49-53.